glp-1 cancer Receptor Agonists: Benefits and Risks in Colorectal Long-term cancer risk in users

To make an informed choice, its important to look at the data

The kidneys and liver metabolise the fatty acids, producing ketone bodies as common metabolites [56]

Stefan N, Ramsauer M, Jordan P et al (2014) Inhibition of 11beta-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

Formulating with collagen also comes with added benefits, as it provides support for skin, hair, joints, gut health and mobility

For the SGLT2i cohort, we included patients who had received an SGLT2i for at least 6 months (Fig

The metabolic and cardiovascular benefits of GLP-1 receptor agonists significantly outweigh this temporary cosmetic concern